ACE and acute kidney injury: Among patients admitted with normal renal function, inpatient administration of an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker (which was determined by the critical care or vascular surgery team on a per-patient basis) was associated with a lower risk for developing AKI (30 vs. 54%, P = 0.01) on univariate analysis.